Business Context and Reporting Period
This Form 8-K Current Report was filed by Muscle Maker, Inc. (trading symbol: GRIL) on April 12, 2021, covering events occurring on April 6, 2021, and April 7, 2021. The company is an emerging growth company incorporated in Nevada. The filing primarily announces the entry into a material definitive agreement for a private placement of equity securities.
Key Financial Metrics and Transaction Details
The filing details a private placement transaction rather than standard periodic financial results. Key metrics related to the transaction include:
- Total Proceeds: Approximately $10,000,000.
- Securities Issued:
- 1,250,000 shares of Common Stock.
- Common Warrants to purchase up to 4,115,227 shares.
- Pre-Funded Warrants to purchase up to 2,865,227 shares.
- Offering Prices:
- Common Stock + Common Warrant: $2.43 per unit.
- Pre-Funded Warrant + Common Warrant: $2.42 per unit.
- Placement Agent Fees: 8% cash fee of gross proceeds plus a warrant to purchase shares equal to 4% of the total shares and warrant shares sold (exercise price $2.916).
The filing text does not provide clear values for revenue, profit, cash flow, operating margins, existing debt, or liquidity positions outside of the proceeds from this specific transaction.
Material Changes
The primary material change is the capitalization structure resulting from the private placement closed on April 9, 2021. The company has increased its cash position by approximately $10 million and issued significant new equity and warrant instruments. The filing does not provide comparative financial data against a prior period to assess changes in operational performance.
Guidance, Outlook, and Risks
Management Commentary and Obligations: The Company is required to file a registration statement with the SEC within 30 days of the agreement (by mid-May 2021) and use commercially reasonable efforts to have it declared effective within 90 days of the closing. The Pre-Funded Warrants are immediately exercisable at $0.01 per share, while Common Warrants are exercisable at $2.43 per share and expire in 5.5 years.
Risks and Contingencies: The securities were issued under Section 4(a)(2) and/or Rule 506 of Regulation D exemptions. They are not registered under the Securities Act and may not be offered or sold in the United States absent registration or an applicable exemption. The filing includes customary representations, warranties, and indemnification obligations.
Investor Verification Checklist
- Verify the effective date of the registration statement required for the resale of the issued shares and warrants.
- Confirm the exact dilution impact on existing shareholders given the issuance of 1,250,000 common shares plus the potential exercise of over 7 million warrants.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants or restrictions not detailed in the summary.
- Check subsequent filings to confirm the placement agent fees were paid and the registration statement was filed within the mandated 30-day window.
- Assess the company's current cash burn rate to determine how long the $10 million in proceeds will sustain operations.